Management Team

Mr. Daly has over 20 years of experience in medical device sales, marketing, international marketing and leadership positions throughout the Johnson & Johnson organization including Ethicon Endo-Surgery, Ethicon Products, J&J Medical Australia/New Zealand, J&J Medical Asia Pacific and Cohera Medical, Inc.^® Within Johnson & Johnson, he held positions of increasing responsibility in marketing, international marketing and sales. He successfully launched a surgical technology business in Australia and created and implemented the first-ever regulatory review of safety and efficacy of that new technology by the Australian Government. He continued his Johnson & Johnson entrepreneurial-like career track as a marketing leader in J&J Medical Asia Pacific by creating and implementing training and development programs in China, India, Korea, Singapore, and the Philippines. Mr. Daly started Cohera Medical in January 2006 and led three successful funding rounds of over $40.5M in capital from private investors to facilitate Cohera Medical’s lead product TissuGlu^® Surgical Adhesive through the FDA approval process for medical devices. Prior to joining Cohera Medical and Johnson & Johnson, Mr. Daly spent over four years on active duty in the U.S. Army as a field artillery officer serving around the world. A native of New York, he is a graduate of the U.S. Military Academy at West Point where he received a B.S. in Engineering with a concentration in Latin American Studies. He played varsity lacrosse during his four years at West Point and was an All-American. Mr. Daly serves on the Board of the Pittsburgh Technology Council and Girls Hope, a nonprofit that provides a well-balanced, nurturing home and quality education through college for academically capable girls. He is also a member of the Young Presidents Organization.

Dr. Beckman is a co-founder of Cohera Medical, Inc.^® and is the primary inventor of the company’s proprietary adhesive technology. He joins Cohera Medical on an entrepreneurial leave of absence from his position as George Bevier Professor of Engineering at the University of Pittsburgh’s Department of Chemical Engineering, where Dr. Beckman is also co-Director of the Mascaro Sustainability Initiative. Dr. Beckman received his Ph.D. in Polymer Science and Engineering from the University of Massachusetts. He has held positions in industry, including positions at Monsanto Plastics and Resins and Union Carbide’s Silicones and Urethanes Intermediates Division. Dr. Beckman received the 2002 Academic Presidential Green Chemistry Challenge Award from the EPA, and was honored by the Engineers’ Society of Western Pennsylvania as the 2005 Engineer of the Year.

Dr. Clower was instrumental in the early formation of Cohera Medical, Inc.^® dating back to 2003 and led the development of Cohera Medical from its ideation to its successful seed financing. She currently leads Cohera Medical’s R&D efforts, and her team successfully brought the company’s lead product TissuGlu^® Surgical Adhesive from laboratory prototype through human clinical trials. Prior to joining Cohera Medical, she specialized in commercializing early-stage technologies through her leadership position in the University of Pittsburgh’s Office of Enterprise Development. Dr. Clower is a neuroscientist and chemist with over twenty years of research experience in both industrial and academic environments. Her work has been published in Nature, Journal of Neuroscience, Journal of Neurophysiology, Cerebral Cortex and Plastic and Reconstructive Surgery. She also brings experience from Baxter Healthcare where she worked on the development of pre-mixed I.V. drug delivery systems within Baxter’s Pharmaceutical R&D Division. Dr. Clower holds a B.A. in Chemistry from Northwestern University in Chicago and a Ph.D. in Neuroscience from Emory University in Atlanta.

Mr. Coberly has more than 20 years of experience in the medical device industry, primarily in the areas of regulatory/clinical affairs, compliance, quality systems, intellectual property, business development, litigation and general legal affairs. Prior to joining Cohera Medical, Inc.^®, he served as the VP of Legal and Regulatory Affairs for Zassi Medical Evolutions, where he led the regulatory and legal aspects of the Worldwide commercialization and later the successful divestiture of a gastrointestinal catheter line. He brings intellectual property experience from the law firm of Howard and Howard, and the Surgical Group of the Stryker Corporation where he held regulatory and legal related positions. He has published articles in Food and Drug Law Institute publications and has held board-level positions with Medical Device Associations. Mr. Coberly holds a J.D. from Michigan State University and a bachelor’s degree in biomedical engineering from Tulane University. He also has completed M.B.A. studies at Boston University. He is admitted to practice before the U.S. Patent and Trademark Office and is a member of the Michigan Bar.

Mr. Wonsettler has more than 20 years of financial management experience with emerging private and public companies. Prior to joining Cohera Medical, Inc.^®, he was the CFO for Active Media/ClubCom, Inc., venture-capital- backed, start-up companies in Pittsburgh, PA for which he built the accounting and treasury departments. Prior to this, Mr. Wonsettler was the CFO and Treasurer for SMT Health Services, Inc. (SMT), a Wexford, PA based healthcare services provider. He was the head of SMT’s finance department when the company was owned by private equity firm Apollo Management L.P. He has also served as an independent financial consultant to early stage venture-capital backed companies and earlier in his career, he was an audit professional with KPMG L.L.P. In addition, Mr. Wonsettler has extensive mergers and acquisition experience and has been directly involved in completing numerous transactions. He is a Certified Public Accountant and a member of the Pennsylvania Institute of Certified Public Accountants (PICPA). He received a Bachelor’s degree of accounting from Washington and Jefferson College in Washington, PA.

Mr. Pearson has more than 20 years of experience in international sales and marketing of medical devices and has been responsible for the introduction of new products in surgical oncology, minimally invasive surgery, orthopedics, general surgery and infection prevention. Most recently, he was vice president, international, at Salient Surgical Technologies Inc. He led the introduction of the company’s saline-enhanced radiofrequency product platform to the European markets and was responsible for all markets outside of the U.S. in 2005. Prior to that, he was responsible for opening one of the first international subsidiaries of STERIS Corporation, where he established successfully the SYSTEM 1 low temperature liquid sterilization system as a market leader in Italy. Mr. Pearson holds a Bachelor’s degree in analytic philosophy from Pomona College and has continuously pursued his interests in new market development, entrepreneurial business, languages, cross cultural communications and management. He is located in Northern Italy.

Mr. Cotter has over 30 years of product development, manufacturing and logistics experience in the medical device, diagnostics, biologics and life science industries. He was most recently the VP of Operations at Helicos BioSciences, a Cambridge, MA, start up involved in the development and production of True Single Molecule- DNA Sequencing&™; technology. Mr. Cotter was the VP of Operations at Closure Medical Corp. for 10 years, a medical device company that developed and commercialized the first synthetic topical skin adhesive to be approved by the U.S. Food and Drug Administration. In addition to his operations role at Closure Medical, he was the development project leader and co-inventor of the Dermabond Topical Skin Adhesive ProPen delivery applicator, which won the 2004 Medical Design Excellence Gold Medal Award. He was part of the senior management team that was involved in the successful acquisition of the company by Johnson & Johnson in 2005. Prior to Closure Medical, Mr. Cotter spent eight years with Sanofi Diagnostics Pasteur, where he had responsibility for all North American plant sites and chaired the world-wide manufacturing committee for this international in-vitro diagnostics company. Before that he held operations management positions of increasing responsibilities with Advanced Technology Laboratories (now part of Phillips Medical) and Genetic Systems Corp. (now part of Bio-Rad). Mr. Cotter is listed as co-inventor on 8 patents and has a Bachelor of Arts degree in political science from Ohio University.